Simultaneous Confidence Corridors for neuroimaging data analysis: applications to Alzheimer's Disease diagnosis
Authors:
Juan A. Arias,
Carmen Cadarso-Suárez,
Pablo Aguiar-Fernández
Abstract:
Alzheimer's disease (AD) is a chronic neurodegenerative condition responsible for most cases of dementia and considered as one of the greatest challenges for neuroscience in this century. Early Ad signs are usually mistaken for normal age-related cognitive dysfunctions, thus patients usually start their treatment in advanced AD stages, when its benefits are severely limited. AD has no known cure,…
▽ More
Alzheimer's disease (AD) is a chronic neurodegenerative condition responsible for most cases of dementia and considered as one of the greatest challenges for neuroscience in this century. Early Ad signs are usually mistaken for normal age-related cognitive dysfunctions, thus patients usually start their treatment in advanced AD stages, when its benefits are severely limited. AD has no known cure, as such, hope lies on early diagnosis which usually depends on neuroimaging techniques such as Positron Emission Tomography (PET). PET data is then analyzed with Statistical Parametric Map** (SPM) software, which uses mass univariate statistical analysis, inevitably incurring in errors derived from this multiple testing approach. Recently, Wang et al. (2020) formulated an alternative: applying functional data analysis (FDA), a relatively new branch of statistics, to calculate mean function and simultaneous confidence corridors (SCCs) for the difference between two groups' PET values. Here we test this approach with a practical application for AD diagnosis, estimating mean functions and SCCs for the difference between AD and control group's PET activity and locating regions where this difference galls outside estimated SCCs, indicating differences in brain activity attributable to AD-derived neural loss. Our results are consistent with previous literature on AD pathology and suggest that this FDA approach is more resilient to reductions in sample size and less dependent on ad hoc selection of an α level than its counterpart, suggesting that this novel technique is a promising venue for research in the field of medical imaging.
△ Less
Submitted 22 January, 2021;
originally announced February 2021.
Data Science in Biomedicine
Authors:
Yovaninna Alarcón-Soto,
Jenifer Espasandín-Domínguez,
Ipek Guler,
Mercedes Conde-Amboage,
Francisco Gude-Sampedro,
Klaus Langohr,
Carmen Cadarso-Suárez,
Guadalupe Gómez-Melis
Abstract:
We highlight the role of Data Science in Biomedicine. Our manuscript goes from the general to the particular, presenting a global definition of Data Science and showing the trend for this discipline together with the terms of cloud computing and big data. In addition, since Data Science is mostly related to areas like economy or business, we describe its importance in biomedicine. Biomedical Data…
▽ More
We highlight the role of Data Science in Biomedicine. Our manuscript goes from the general to the particular, presenting a global definition of Data Science and showing the trend for this discipline together with the terms of cloud computing and big data. In addition, since Data Science is mostly related to areas like economy or business, we describe its importance in biomedicine. Biomedical Data Science (BDS) presents the challenge of dealing with data coming from a range of biological and medical research, focusing on methodologies to advance the biomedical science discoveries, in an interdisciplinary context.
△ Less
Submitted 9 September, 2019;
originally announced September 2019.
